Ark Biosciences

company

About

Ark Biosciences is a biopharmaceutical company that is dedicated to the discovery and development

  • 51 - 100

Details

Last Funding Type
Series C
Last Funding Money Raised
$86K
Industries
Biopharma,Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2014
Number Of Employee
51 - 100
Operating Status
Active

Ark Biosciences is a biopharmaceutical company that is dedicated to the discovery and development of innovative therapeutics to address unmet medical need, especially in the area of respiratory viral infection and viral hepatitis, for global and China market.
We strive to build a science-driven biopharmaceutical company that aims to be a leader in antiviral drug discovery and development. To achieve so, we aspire for the excellence of science and be innovative. We operate with a razor-sharp focus and aggressiveness with a timely and cost efficient manner. We create a healthy and rewarding work environment for employees, and seek a superior rate of return for investors and partners.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$86K
Ark Biosciences has raised a total of $86K in funding over 2 rounds. Their latest funding was raised on Jul 14, 2022 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 14, 2022 Series D 1 Detail
Jan 22, 2021 Series C $86K 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Ark Biosciences is funded by 2 investors. Longda Foods and TPG are the most recent investors.
Investor Name Lead Investor Funding Round
Longda Foods Series D
TPG Series C